microRNA and transcription factor mediated regulatory network for ovarian cancer Regulatory network of ovarian cancer

被引:9
作者
Ying, Huanchun [1 ]
Lv, Jing [2 ]
Ying, Tianshu [1 ]
Li, Jun [1 ]
Yang, Qing [1 ]
Ma, Yuan [3 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Gynecol & Obstet, Shenyang 110004, Liaoning Provin, Peoples R China
[2] Fifth Hosp Shenyang, Dept Oncol, Shenyang 110023, Peoples R China
[3] Anyang Tumor Hosp, Dept Gynecol 1, Anyang 455000, Hennan Province, Peoples R China
基金
上海市科技启明星计划;
关键词
Ovarian cancer; Differentially expressed genes; MicroRNA; Transcription factor; Target genes; Interaction network; CELL-CYCLE ARREST; DOWN-REGULATION; EXPRESSION; FAMILY; PROLIFERATION; P21; OVEREXPRESSION; GENE;
D O I
10.1007/s13277-013-0892-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A better understanding on the regulatory interactions of microRNA (miRNA) target genes and transcription factor (TF) target genes in ovarian cancer may be conducive for developing early diagnosis strategy. Thus, gene expression data and miRNA expression data were downloaded from The Cancer Genome Atlas in this study. Differentially expressed genes and miRNAs were selected out with t test, and Gene Ontology enrichment analysis was performed with DAVID tools. Regulatory interactions were retrieved from miRTarBase, TRED, and TRANSFAC, and then networks for miRNA target genes and TF target genes were constructed to globally present the mechanisms. As a result, a total of 1,939 differentially expressed genes were identified, and they were enriched in 28 functions, among which cell cycle was affected to the most degree. Besides, 213 differentially expressed miRNAs were identified. Two regulatory networks for miRNA target genes and TF target genes were established and then both were combined, in which E2F transcription factor 1, cyclin-dependent kinase inhibitor 1A, cyclin E1, and miR-16 were the hub genes. These genes may be potential biomarkers for ovarian cancer.
引用
收藏
页码:3219 / 3225
页数:7
相关论文
共 38 条
[1]   Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition [J].
Bendoraite, Ausra ;
Knouf, Emily C. ;
Garg, Kavita S. ;
Parkin, Rachael K. ;
Kroh, Evan M. ;
O'Briant, Kathy C. ;
Ventura, Aviva P. ;
Godwin, Andrew K. ;
Karlan, Beth Y. ;
Drescher, Charles W. ;
Urban, Nicole ;
Knudsen, Beatrice S. ;
Tewari, Muneesh .
GYNECOLOGIC ONCOLOGY, 2010, 116 (01) :117-125
[2]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[3]   MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer [J].
Bhattacharya, Resham ;
Nicoloso, Milena ;
Arvizo, Rochelle ;
Wang, Enfeng ;
Cortez, Angelica ;
Rossi, Simona ;
Calin, George A. ;
Mukherjee, Priyabrata .
CANCER RESEARCH, 2009, 69 (23) :9090-9095
[4]   Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial [J].
Buys, Saundra S. ;
Partridge, Edward ;
Black, Amanda ;
Johnson, Christine C. ;
Lamerato, Lois ;
Isaacs, Claudine ;
Reding, Douglas J. ;
Greenlee, Robert T. ;
Yokochi, Lance A. ;
Kessel, Bruce ;
Crawford, E. David ;
Church, Timothy R. ;
Andriole, Gerald L. ;
Weissfeld, Joel L. ;
Fouad, Mona N. ;
Chia, David ;
O'Brien, Barbara ;
Ragard, Lawrence R. ;
Clapp, Jonathan D. ;
Rathmell, Joshua M. ;
Riley, Thomas L. ;
Hartge, Patricia ;
Pinsky, Paul F. ;
Zhu, Claire S. ;
Izmirlian, Grant ;
Kramer, Barnett S. ;
Miller, Anthony B. ;
Xu, Jian-Lun ;
Prorok, Philip C. ;
Gohagan, John K. ;
Berg, Christine D. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (22) :2295-2303
[5]   Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells [J].
Cariou, S ;
Donovan, JCH ;
Flanagan, WM ;
Milic, A ;
Bhattacharya, N ;
Slingerland, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :9042-9046
[6]   Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].
Chin, L. ;
Meyerson, M. ;
Aldape, K. ;
Bigner, D. ;
Mikkelsen, T. ;
VandenBerg, S. ;
Kahn, A. ;
Penny, R. ;
Ferguson, M. L. ;
Gerhard, D. S. ;
Getz, G. ;
Brennan, C. ;
Taylor, B. S. ;
Winckler, W. ;
Park, P. ;
Ladanyi, M. ;
Hoadley, K. A. ;
Verhaak, R. G. W. ;
Hayes, D. N. ;
Spellman, Paul T. ;
Absher, D. ;
Weir, B. A. ;
Ding, L. ;
Wheeler, D. ;
Lawrence, M. S. ;
Cibulskis, K. ;
Mardis, E. ;
Zhang, Jinghui ;
Wilson, R. K. ;
Donehower, L. ;
Wheeler, D. A. ;
Purdom, E. ;
Wallis, J. ;
Laird, P. W. ;
Herman, J. G. ;
Schuebel, K. E. ;
Weisenberger, D. J. ;
Baylin, S. B. ;
Schultz, N. ;
Yao, Jun ;
Wiedemeyer, R. ;
Weinstein, J. ;
Sander, C. ;
Gibbs, R. A. ;
Gray, J. ;
Kucherlapati, R. ;
Lander, E. S. ;
Myers, R. M. ;
Perou, C. M. ;
McLendon, Roger .
NATURE, 2008, 455 (7216) :1061-1068
[7]   MicroRNAs Play a Big Role in Regulating Ovarian Cancer-Associated Fibroblasts and the Tumor Microenvironment [J].
Chou, Jonathan ;
Werb, Zena .
CANCER DISCOVERY, 2012, 2 (12) :1078-1080
[8]  
Crijns APG, 2009, PLOS MED, V6, P181, DOI 10.1371/journal.pmed.1000024
[9]   Prognostication of prostate cancer based on TOP2A protein and gene assessment: TOP2A in prostate cancer [J].
de Resende, Marina Frana ;
Vieira, Samantha ;
Domingos Chinen, Ludmilla Thome ;
Chiappelli, Francesco ;
da Fonseca, Francisco Paulo ;
Guimaraes, Gustavo Cardoso ;
Soares, Fernando Augusto ;
Neves, Ivan ;
Pagotty, Simone ;
Pellionisz, Peter A. ;
Barkhordarian, Andre ;
Brant, Xenia ;
Rocha, Rafael Malagoli .
JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
[10]   Identifying MicroRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis [J].
Fu, Jihong ;
Tang, Wentao ;
Du, Peng ;
Wang, Guanghui ;
Chen, Wei ;
Li, Jingming ;
Zhu, Yunxiang ;
Gao, Jun ;
Cui, Long .
BMC SYSTEMS BIOLOGY, 2012, 6